Zobrazeno 1 - 10
of 2 970
pro vyhledávání: '"P. Galetta"'
Autor:
Annarita Fanizzi, Annamaria Catino, Samantha Bove, Maria Colomba Comes, Michele Montrone, Angela Sicolo, Rahel Signorile, Pia Perrotti, Pamela Pizzutilo, Domenico Galetta, Raffaella Massafra
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionMalignant pleural mesothelioma (MPM) is a poor-prognosis disease. Owing to the recent availability of new therapeutic options, there is a need to better assess prognosis. The initial clinical response could represent a useful parameter.Me
Externí odkaz:
https://doaj.org/article/3b046e21ce07461792ec79d50f98d1aa
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/aecf32652e71422c9df014b80bfc237f
Autor:
Neil A. Busis, Dilshad Marolia, Robert Montgomery, Laura J. Balcer, Steven L. Galetta, Scott N. Grossman
Publikováno v:
npj Digital Medicine, Vol 7, Iss 1, Pp 1-5 (2024)
Digital health technologies (DHTs) can transform neurological assessments, improving quality and continuity of care. In the United States, the Food & Drug Administration (FDA) oversees the safety and efficacy of these technologies, employing a detail
Externí odkaz:
https://doaj.org/article/e861d8d98427489291486f68fda3ff90
Autor:
Lara Girelli, Luca Bertolaccini, Monica Casiraghi, Francesco Petrella, Domenico Galetta, Antonio Mazzella, Stefano Donghi, Giorgio Lo Iacono, Andrea Cara, Juliana Guarize, Lorenzo Spaggiari
Publikováno v:
Current Oncology, Vol 30, Iss 12, Pp 10437-10449 (2023)
Background: Sleeve lobectomy with bronchoplasty is a safe surgical technique for the management of lung cancer and endobronchial localization of extrapulmonary cancers. However, anastomotic complications can occur, and treatment strategies are not st
Externí odkaz:
https://doaj.org/article/9fe88e5c1c174b8ba6b26d1717df04b3
Autor:
Annarita Fanizzi, Federico Fadda, Maria Colomba Comes, Samantha Bove, Annamaria Catino, Erika Di Benedetto, Angelo Milella, Michele Montrone, Annalisa Nardone, Clara Soranno, Alessandro Rizzo, Deniz Can Guven, Domenico Galetta, Raffaella Massafra
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Non-Small cell lung cancer (NSCLC) is one of the most dangerous cancers, with 85% of all new lung cancer diagnoses and a 30–55% of recurrence rate after surgery. Thus, an accurate prediction of recurrence risk in NSCLC patients during diag
Externí odkaz:
https://doaj.org/article/355cb18e617c4a91bae039c14b60162d
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 11, Iss 6, Pp 1648-1649 (2024)
Externí odkaz:
https://doaj.org/article/bf1fbc51921f43f5b7a43319d90c8e7b
Publikováno v:
Microbiologia Medica, Vol 20, Iss 3 (2005)
Externí odkaz:
https://doaj.org/article/f80e5de699e040bfbfbf67db2ffb30eb
Autor:
P. Galetta, E. Filetici, A.M. Dionisi, S. Arena, M. Massari, S. Bilei, A. Piccoli, M. Napoli, R. Trinito, R. Loffredo, V. Gnesivo, A. Pendenza, A. Tozzi, I. Luzzi
Publikováno v:
Microbiologia Medica, Vol 20, Iss 3 (2005)
Externí odkaz:
https://doaj.org/article/a7fe46fe7ab740e7bd895a8ba8508b69
Autor:
P. Galetta, A. Caprioli, A. Tozzi, S. Arena, E. Filetici, A.M. Dionisi, S. Lana, S. Owczarek, I. Luzzi
Publikováno v:
Microbiologia Medica, Vol 18, Iss 2 (2003)
Externí odkaz:
https://doaj.org/article/fc2b04511d3a41f48e086a7177b756c1
Autor:
Vito Longo, Carminia Maria Della Corte, Alessandro Russo, Francesca Spinnato, Francesca Ambrosio, Riccardo Ronga, Antonella Marchese, Teresa Del Giudice, Concetta Sergi, Francesca Casaluce, Marina Gilli, Michele Montrone, Valerio Gristina, Vincenzo Sforza, Maria Lucia Reale, Raimondo Di Liello, Alberto Servetto, Helga Lipari, Claudio Longhitano, Laura Vizzini, Anna Manzo, Antonella Cristofano, Loretta Paolelli, Annalisa Nardone, Simona De Summa, Antonella Perrone, Carmela Bisceglia, Caterina Derosa, Valerio Nardone, Giuseppe Viscardi, Domenico Galetta, Fabiana Vitiello
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
BackgroundConsolidative thoracic radiotherapy (TRT) has been commonly used in the management of extensive-stage small cell lung cancer (ES-SCLC). Nevertheless, phase III trials exploring first-line chemoimmunotherapy have excluded this treatment appr
Externí odkaz:
https://doaj.org/article/0916d9972ccf47d690c1cb596c1e055d